Diabetes is a leading cause of vision loss in the United States, and cataracts are a common complication of the disease. With ...

A new study published in Nature Mental Health has found that people with a higher genetic risk for schizophrenia tend to have ...

Cones outnumber rods only in the center of the retina, which is the area of greatest density. It is also the area most ...

Optical coherence tomography is beneficial for measuring visual changes and the impact of comorbidities in MS, NMOSD, and ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

A new educational article from Modern Vision Solutions reveals a growing body of evidence that underscores the critical role ...

Researchers have uncovered a surprising connection between a cancer-related signaling pathway and the blood-brain and blood-retina barriers.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously ...

Atsena Therapeutics expands its ATSN-201 trial for X-linked retinoschisis, a step toward the first gene therapy treatment.

The biotech will add a pivotal Phase III cohort to its ongoing Phase I/II trial evaluating ATSN-201 in X-linked retinoschisis ...

The prevalence and incidence of diabetic retinal disease (DRD) has increased in recent years, while the incidence of vision-threatening diabetic retinopathy (VTDR), diabetic macular edema (DME), and ...